Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease
Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the cardiovascular effects of pioglitazone, once
daily (QD), versus glyburide when administered to patients with type 2 diabetes mellitus and
mild cardiac disease.